Dalal SR, Chang EB. The microbial basis of inflammatory bowel diseases. J Clin Invest. 2014;124(10):4190–6.

Article  PubMed  PubMed Central  Google Scholar 

Kobayashi T, Siegmund B, Le Berre C, Wei SC, Ferrante M, Shen B, et al. Ulcerative colitis. Nat Reviews Disease Primers. 2020;6(1):74.

Article  PubMed  Google Scholar 

Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet. 2017;389(10080):1756–70.

Article  PubMed  Google Scholar 

Athanasakos A, Mazioti A, Economopoulos N, Kontopoulou C, Stathis G, Filippiadis D, et al. Inflammatory bowel disease—the role of cross-sectional imaging techniques in the investigation of the small bowel. Insights into Imaging. 2015;6(1):73–83.

Article  PubMed  Google Scholar 

Weiser M, Simon JM, Kochar B, Tovar A, Israel JW, Robinson A, et al. Molecular classification of Crohn’s disease reveals two clinically relevant subtypes. Gut. 2018;67(1):36–42.

Article  CAS  PubMed  Google Scholar 

Ahluwalia B, Moraes L, Magnusson MK, Öhman L. Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies. Scand J Gastroenterol. 2018;53(4):379–89.

Article  PubMed  Google Scholar 

Khorsand B, Asadzadeh Aghdaei H, Nazemalhosseini-Mojarad E, Nadalian B, Nadalian B, Houri H. Overrepresentation of Enterobacteriaceae and Escherichia coli is the major gut microbiome signature in Crohn’s disease and ulcerative colitis; a comprehensive metagenomic analysis of IBDMDB datasets. Front Cell Infect Microbiol. 2022;12.

Sekirov I, Tam NM, Jogova M, Robertson ML, Li Y, Lupp C, et al. Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect Immun. 2008;76(10):4726–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Castanheira M, Simner PJ, Bradford PA. Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection. JAC-Antimicrobial Resist. 2021;3(3).

Gutiérrez-Gutiérrez B, Rodríguez-Baño J. Current options for the treatment of infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in different groups of patients. Clin Microbiol Infect. 2019;25(8):932–42.

Article  PubMed  Google Scholar 

Vaisman A, Pivovarov K, McGeer A, Willey B, Borgundvaag B, Porter V, et al. Prevalence and incidence of antimicrobial-resistant organisms among hospitalized inflammatory bowel disease patients. Can J Infect Dis Med Microbiol. 2013;24(4):e117–21.

Article  PubMed  PubMed Central  Google Scholar 

Ananthakrishnan AN, McGinley EL. Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases. J Crohns Colitis. 2013;7(2):107–12.

Article  PubMed  Google Scholar 

Magro F, Langner C, Driessen A, Ensari A, Geboes K, Mantzaris GJ, et al. European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis. 2013;7(10):827–51.

Article  CAS  PubMed  Google Scholar 

Li P, Zhang D, Li H, Pang J, Guo H, Qiu J. Establishment and application of Multiplex PCR for simultaneously detecting Escherichia coli, Salmonella, Klebsiella pneumoniae, and Staphylococcus aureus in Minks. Front Vet Sci. 2020;7:588173.

Article  PubMed  PubMed Central  Google Scholar 

Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 30 ed2021.

Nordmann P, Poirel L, Dortet L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2012;18(9):1503–7.

Article  PubMed  PubMed Central  Google Scholar 

Pasteran F, Tijet N, Melano RG, Corso A. Simplified protocol for Carba NP Test for enhanced detection of Carbapenemase Producers directly from bacterial cultures. J Clin Microbiol. 2015;53(12):3908–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dallenne C, Da Costa A, Decré D, Favier C, Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae. J Antimicrob Chemother. 2010;65(3):490–5.

Article  CAS  PubMed  Google Scholar 

Trung NT, Hien TT, Huyen TT, Quyen DT, Binh MT, Hoan PQ, et al. Simple multiplex PCR assays to detect common pathogens and associated genes encoding for acquired extended spectrum betalactamases (ESBL) or carbapenemases from surgical site specimens in Vietnam. Ann Clin Microbiol Antimicrob. 2015;14:23.

Article  PubMed  PubMed Central  Google Scholar 

Olbjørn C, Cvancarova Småstuen M, Thiis-Evensen E, Nakstad B, Vatn MH, Jahnsen J, et al. Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease - associations with disease phenotype, treatment, and outcome. Clin Exp Gastroenterol. 2019;12:37–49.

Article  PubMed  PubMed Central  Google Scholar 

Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012;13(9):R79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mukhopadhya I, Hansen R, El-Omar EM, Hold GL. IBD-what role do Proteobacteria play? Nat Rev Gastroenterol Hepatol. 2012;9(4):219–30.

Article  CAS  PubMed  Google Scholar 

Piewngam P, Quiñones M, Thirakittiwatthana W, Yungyuen T, Otto M, Kiratisin P. Composition of the intestinal microbiota in extended-spectrum β-lactamase-producing Enterobacteriaceae carriers and non-carriers in Thailand. Int J Antimicrob Agents. 2019;53(4):435–41.

Article  CAS  PubMed  Google Scholar 

Beigverdi R, Jabalameli L, Jabalameli F, Emaneini M. Prevalence of extended-spectrum β-lactamase-producing Klebsiella pneumoniae: first systematic review and meta-analysis from Iran. J Global Antimicrob Resist. 2019;18:12–21.

Article  Google Scholar 

Aghamohammad S, Nikbin VS, Badmasti F, Shahcheraghi F. High heterogeneity of fecal carriage extended-spectrum beta-lactamase-producing E. coli isolated from iranian community and clinical settings. BMC Infect Dis. 2022;22(1):318.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Skuja V, Derovs A, Pekarska K, Rudzite D, Lavrinovica E, Piekuse L, et al. Gut colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae may increase disease activity in biologic-naive outpatients with ulcerative colitis: an interim analysis. Eur J Gastroenterol Hepatol. 2018;30(1):92–100.

Article  CAS  PubMed  Google Scholar 

Leung W, Malhi G, Willey BM, McGeer AJ, Borgundvaag B, Thanabalan R, et al. Prevalence and predictors of MRSA, ESBL, and VRE colonization in the ambulatory IBD population. J Crohns Colitis. 2012;6(7):743–9.

Article  PubMed  Google Scholar 

Roberts LW, Hoi LT, Khokhar FA, Hoa NT, Giang TV, Bui C, et al. Genomic characterisation of multidrug-resistant < em > Escherichia coli, Klebsiella pneumoniae, and < em > Acinetobacter baumannii in two intensive care units in Hanoi, Viet Nam: a prospective observational cohort study. The Lancet Microbe. 2022;3(11):e857–e66.

Article  CAS  PubMed  Google Scholar 

Ibrahim DR, Dodd CER, Stekel DJ, Meshioye RT, Diggle M, Lister M et al. Multidrug-resistant ESBL-Producing E. coli in Clinical samples from the UK. Antibiot (Basel). 2023;12(1).

Gruszecka J, Filip R. Are hospitalized patients with inflammatory bowel disease at increased risk of invasive bacterial infections? Results from POLIBD 3-year cohort study. Gut Pathog. 2021;13(1):12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Joseph L, Merciecca T, Forestier C, Balestrino D, Miquel S. From Klebsiella pneumoniae colonization to dissemination: an overview of studies implementing murine models. Microorganisms. 2021;9(6):1282.

Article  PubMed  PubMed Central  Google Scholar 

Thänert R, Thänert A, Ou J, Bajinting A, Burnham C-AD, Engelstad HJ, et al. Antibiotic-driven intestinal dysbiosis in pediatric short bowel syndrome is associated with persistently altered microbiome functions and gut-derived bloodstream infections. Gut Microbes. 2021;13(1):1940792.

Article  PubMed  PubMed Central  Google Scholar 

Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy C. Infectious diseases society of america antimicrobial resistant treatment guidance: gram-negative bacterial infections. Practice. 2020;6(8).

Doi Y. Treatment Options for Carbapenem-resistant Gram-negative bacterial infections. Clin Infect Dis. 2019;69(Supplement7):565–S75.

Article  Google Scholar 

Yuan W, Xu J, Guo L, Chen Y, Gu J, Zhang H, et al. Clinical risk factors and microbiological and intestinal characteristics of carbapenemase-producing < i > Enterobacteriaceae colonization and subsequent infection. Microbiol Spectr. 2022;10(6):e01906–21.

Article  PubMed  PubMed Central  Google Scholar 

Garrett WS, Gallini CA, Yatsunenko T, Michaud M, DuBois A, Delaney ML, et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe. 2010;8(3):292–300.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chandra H, Sharma KK, Tuovinen OH, Sun X, Shukla P. Pathobionts: mechanisms of survival, expansion, and interaction with host with a focus on Clostridioides difficile. Gut Microbes. 2021;13(1):1979882.

Article  PubMed  PubMed Central  Google Scholar 

Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005;18(4):657–86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tolun V, Küçükbasmaci Ö, Törümküney-Akbulut D, Çatal Ç, Anğ-Küçüker M, Auğ Ö. Relationship between ciprofloxacin resistance and extended-spectrum β-lactamase production in Escherichia coli and Klebsiella pneumoniae strains. Clin Microbiol Infect. 2004;10(1):72–5.

Article  CAS  PubMed